AMENDMENT TO OPTION, COLLABORATION AND LICENSE AGREEMENTOption, Collaboration and License Agreement • October 4th, 2019 • Conatus Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Amendment (“Amendment”) to the Option, Collaboration and License Agreement dated as of the 19th day of December, 2016 by and between Novartis Pharma AG, a corporation organized and existing under the laws of Switzerland (“Novartis”), and Conatus Pharmaceuticals Inc., a corporation organized and existing under the laws of the State of Delaware, U.S.A. (“Conatus”), (the “Agreement”), is made and effective as of September 30th, 2019 (the “Amendment Effective Date”). Any capitalized terms used but not otherwise defined herein shall have the meaning set forth in the Agreement.
